Cholesterol Medication Helps Lower Blood Glucose Levels!
A moderately new medicine employed for lowering cholesterol levels, colesevalam, has in addition been found to be helpful in lowering blood sugar when applied along with some other medicines for Type two diabetes. It's sometimes prescribed glucotrust for diabetes (visit the following webpage) diabetics that are considered at risk that is high for heart and blood vessel disease. It is now being studied for potential use by prediabetics.
In September 2010, the medical journal Endocrinology Practice published the results of an investigation performed at the Metabolic Institute of America, Tarzana, United States. The authors learned 216 adults with untreated prediabetes. Half were given colesevelam and half were given a placebo. After sixteen weeks the participants taking the colesevelam had:
Significantly more participants taking the drug likewise achieved:
Hemoglobin A1c levels indicate just how well blood glucose, or maybe sugar, is managed over a 4 month period. The authors concluded that colesevelam can be ideal for both blood as well as cholesterol sugar control in prediabetics. In addition they speculated that much more research is warranted to discover whether the drug might stop individuals clinically determined to have prediabetes from progressing onto full-blown Type two diabetes.
In September 2010, the medical journal Endocrinology Practice published the results of an investigation performed at the Metabolic Institute of America, Tarzana, United States. The authors learned 216 adults with untreated prediabetes. Half were given colesevelam and half were given a placebo. After sixteen weeks the participants taking the colesevelam had:
Significantly more participants taking the drug likewise achieved:
Hemoglobin A1c levels indicate just how well blood glucose, or maybe sugar, is managed over a 4 month period. The authors concluded that colesevelam can be ideal for both blood as well as cholesterol sugar control in prediabetics. In addition they speculated that much more research is warranted to discover whether the drug might stop individuals clinically determined to have prediabetes from progressing onto full-blown Type two diabetes.
